Project Details
| Status | Active |
|---|---|
| Effective start/end date | 4/12/24 → 4/12/27 |
Funding
- PPD Investigator Services, LLC (Prot #BHV7000-302 // Prot #BHV7000-302)
- Biohaven Pharmaceuticals, Inc. (Prot #BHV7000-302 // Prot #BHV7000-302)
Prot #BHV7000-302: A Phase 2/3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy, Safety and Tolerability of BHV-7000 in Subjects withRefractory Focal Onset Epilepsy
- Macken, Micheal P (PD/PI)
Project: Research project